A Phase II Study of Prolonged Oral Etoposide in Advanced or Recurrent Carcinoma of the Cervix
- 1 August 1998
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 70 (2) , 215-218
- https://doi.org/10.1006/gyno.1998.5061
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Phase II study of oral etoposide for patients with advanced breast cancerCancer, 1995
- Phase II study of prolonged oral etoposide in combination with intravenous cisplatin in advanced non-small cell lung cancerLung Cancer, 1995
- Oral etoposide is active against platinum-resistant epithelial ovarian cancer.Journal of Clinical Oncology, 1994
- Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trial.Journal of Clinical Oncology, 1992
- Prospective study of etoposide scheduling in combination chemotherapy for limited disease small cell lung carcinomaEuropean Journal of Cancer and Clinical Oncology, 1991
- Clinical and Histopathologic Factors Predicting Recurrence and Survival After Pelvic Exenteration for Cancer of the CervixObstetrics & Gynecology, 1989
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Phase II study of etoposide (VP-16) in the treatment of advanced head and neck cancerAmerican Journal of Clinical Oncology, 1985
- The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agentJournal of Chronic Diseases, 1961
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958